$256 Million is the total value of HARBOURVEST PARTNERS LLC's 26 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWI | Sell | Solarwinds Corp. | $111,216,000 | -30.5% | 7,439,200 | -5.5% | 43.46% | -26.7% |
| EVLO | Evelo Biosciences, Inc. | $37,038,000 | +129.4% | 3,063,505 | 0.0% | 14.47% | +142.3% | |
| SGTX | New | Sigilon Therapeutics, Inc. | $35,578,000 | – | 740,740 | +100.0% | 13.90% | – |
| KLDO | Sell | Kaleido BioSciences, Inc. | $16,688,000 | -28.8% | 1,833,832 | -4.5% | 6.52% | -24.8% |
| AXLA | Axcella Health, Inc. | $14,573,000 | +12.3% | 2,807,981 | 0.0% | 5.70% | +18.6% | |
| TDOC | TelaDoc Health, Inc. | $10,187,000 | -8.8% | 50,943 | 0.0% | 3.98% | -3.7% | |
| RUBY | Rubius Therapeutics, Inc. | $7,490,000 | +51.5% | 986,878 | 0.0% | 2.93% | +59.9% | |
| LC | LendingClub Corp. | $5,422,000 | +124.2% | 513,440 | 0.0% | 2.12% | +136.8% | |
| LOV | Spark Networks SEsponsored adr | $2,674,000 | +8.8% | 502,576 | 0.0% | 1.04% | +14.8% | |
| WORK | New | Slack Technologies, Inc. | $2,578,000 | – | 61,037 | +100.0% | 1.01% | – |
| ZUO | Zuora, Inc. | $2,283,000 | +34.7% | 163,894 | 0.0% | 0.89% | +42.3% | |
| MCRB | New | Seres Therapeutics, Inc. | $2,056,000 | – | 83,903 | +100.0% | 0.80% | – |
| YEXT | Yext, Inc. | $1,810,000 | +3.5% | 115,147 | 0.0% | 0.71% | +9.3% | |
| ADVM | New | Adverum Biotechnologies, Inc. | $1,454,000 | – | 134,154 | +100.0% | 0.57% | – |
| PGNY | Sell | Progyny, Inc. | $1,261,000 | -51.1% | 29,743 | -66.0% | 0.49% | -48.3% |
| AR | Antero Resources LLC | $719,000 | +98.1% | 131,895 | 0.0% | 0.28% | +109.7% | |
| CTMX | Cytomx Therapeutics, Inc. | $519,000 | -1.5% | 79,193 | 0.0% | 0.20% | +4.1% | |
| TRVN | Trevena, Inc. | $500,000 | -28.5% | 233,850 | 0.0% | 0.20% | -24.7% | |
| CSLT | Castlight Health, Inc. | $454,000 | +15.2% | 349,070 | 0.0% | 0.18% | +21.2% | |
| YMTX | New | Yumanity | $375,000 | – | 22,030 | +100.0% | 0.15% | – |
| XGN | Exagen, Inc. | $343,000 | +21.6% | 25,982 | 0.0% | 0.13% | +28.8% | |
| EPZM | Epizyme, Inc. | $268,000 | -9.2% | 24,686 | 0.0% | 0.10% | -3.7% | |
| New | Rapt Therapeutics, Inc. | $244,000 | – | 12,351 | +100.0% | 0.10% | – | |
| NXTC | NextCure, Inc. | $109,000 | +23.9% | 10,044 | 0.0% | 0.04% | +30.3% | |
| METC | Ramaco Resources, Inc. | $43,000 | -17.3% | 14,951 | 0.0% | 0.02% | -10.5% | |
| HNRG | Hallador Energy Resources, Inc. | $21,000 | +133.3% | 14,270 | 0.0% | 0.01% | +166.7% | |
| REAL | Exit | The RealReal, Inc. | $0 | – | -7,300 | -100.0% | -0.04% | – |
| BDTX | Exit | Black Diamond Therapeutics, Inc. | $0 | – | -9,581 | -100.0% | -0.11% | – |
| ARVN | Exit | Arvinas, Inc. | $0 | – | -16,666 | -100.0% | -0.14% | – |
| PTI | Exit | Proteostasis Therapeutics, Inc. | $0 | – | -440,627 | -100.0% | -0.18% | – |
| LYFT | Exit | Lyft, Inc. | $0 | – | -25,785 | -100.0% | -0.26% | – |
| VCYT | Exit | Veracyte, Inc. | $0 | – | -23,591 | -100.0% | -0.28% | – |
| PHR | Exit | Phreesia, Inc. | $0 | – | -24,562 | -100.0% | -0.29% | – |
| CNST | Exit | Constellation Pharmaceuticals, Inc. | $0 | – | -49,614 | -100.0% | -0.37% | – |
| Exit | Crispr Therapeutics AGnamen akt | $0 | – | -21,439 | -100.0% | -0.66% | – | |
| SFIX | Exit | Stitchfix, Inc. | $0 | – | -66,571 | -100.0% | -0.67% | – |
| PD | Exit | PagerDuty, Inc. | $0 | – | -67,891 | -100.0% | -0.68% | – |
| NTNX | Exit | Nutanix, Inc. | $0 | – | -106,049 | -100.0% | -0.87% | – |
| ISEE | Exit | IVERIC Bio, Inc. | $0 | – | -442,810 | -100.0% | -0.92% | – |
| PS | Exit | PluralSight, Inc. | $0 | – | -176,807 | -100.0% | -1.12% | – |
| ONEM | Exit | 1Life Healthcare, Inc. | $0 | – | -351,480 | -100.0% | -3.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.